Diagnosing neurodevelopmental disorders in adults
Descriptive Study of Adult Patients Diagnosed Later with a Neurodevelopmental Disorder and Their Management
Hospices Civils de Lyon · NCT06691048
This study is looking to see how we can better identify neurodevelopmental disorders like ADHD and autism in adults who were diagnosed after 18, so they can get the support they need.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years to 55 Years |
| Sex | All |
| Sponsor | Hospices Civils de Lyon (other) |
| Locations | 1 site (Bron) |
| Trial ID | NCT06691048 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on identifying neurodevelopmental disorders in adults who were diagnosed after the age of 18. It aims to address the significant number of individuals who remain untreated and symptomatic into adulthood, highlighting the need for a diagnostic pathway for lifelong care. The study will evaluate adults with various neurodevelopmental disorders, including ADHD and autism spectrum disorders, to better understand their cognitive dysfunctions and challenges in socio-professional integration.
Who should consider this trial
Good fit: Ideal candidates for this study are men and women aged 18 to 55 who have been diagnosed with a neurodevelopmental disorder after the age of 18.
Not a fit: Patients with intellectual disabilities or serious psychiatric comorbidities may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and treatment pathways for adults with neurodevelopmental disorders, enhancing their quality of life.
How similar studies have performed: While there is ongoing research into neurodevelopmental disorders, this specific focus on late diagnosis in adulthood is relatively novel and less explored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men or women aged 18 or over * Men or women under 55 years of age * Patients with a neurodevelopmental disorder according to the latest DSM5 criteria diagnosed after age 18 * Patient with sufficient visual and auditory skills, oral and written language in French accessible to clinical and neuropsychological evaluation. Exclusion Criteria: * Patients with intellectual disabilities * Patients with serious addictive and/or psychiatric comorbidities
Where this trial is running
Bron
- Hospices Civils de Lyon — Bron, France (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Neurodevelopmental Disorders, Late diagnosis, Adult